CME Group (CME) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Some insider buying ($661K), but sales were much larger ($43.8M) over the same 12 months.
Past insider buys here: 2 of 3 beat the S&P 500 over the next 90 days (small sample). See each one ↓
Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- 90-day result for William R. Shepard's $79K buy: in on Dec 27, 2026. See the 7- and 30-day results ↓
- Next earnings expected around Jan 20, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Terrence A. Duffy, CEO, Chair sold 17,000 shares at $310.18 ($5.3M).
- Trade date
- Nov 18, 2026
- Disclosed to the SEC
- Nov 19, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All CME insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
CME insider transactions (Form 4)
Open-market purchases and sales. 110 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 19SEC | Terrence A. DuffyCEO, Chair | Sell | 17,00035,442 held (−32%) | $310.18 | $5.3M | +0.3% | — |
| Nov 19SEC | Terrence A. DuffyCEO, Chair | Sell | 10,00052,442 held (−16%) | $308.54 | $3.1M | +0.8% | — |
| Nov 19SEC | John Clifford MarcheseGeneral Counsel | Sell | 6552,943 held (−18%) | $310.75 | $204K | +0.1% | — |
| Nov 10SEC | Daniel G. KayeDirector | Sell | 5324,313 held (−11%) | $304.17 | $162K | +2.3% | — |
| Nov 3SEC | Howard J. SiegelDirector | Sell | 2,00019,873 held (−9%) | $303.00 | $606K | +2.7% | — |
| Nov 2SEC | Julie WinklerSr Md Chief Commercial Officer | Sell | 10,07921,482 held (−32%) | $305.15 | $3.1M | +2.0% | — |
| Oct 27SEC | Sunil CutinhoChief Information Officer | Sell | 5,00020,037 held (−20%) | $298.70 | $1.5M | +4.2% | — |
| Oct 22SEC | Martin J. GepsmanDirector | Sell | 40025,244 held (−2%) | $302.50 | $121K | +2.9% | — |
| Sep 28SEC | William R. ShepardDirectorOff-schedule buyBefore earningsPast buys 9/19 beat S&P | Buy | 293263,289 held (+0%) | $268.76 | $79K | +15.8% | 45 |
| Sep 14SEC | Elizabeth A. CookDirector | Sell | 50017,916 held (−3%) | $280.11 | $140K | +11.1% | — |
| Sep 11SEC | Terrence A. DuffyCEO, Chair | Sell | 14,37241,258 held (−26%) | $274.41 | $3.9M | +13.4% | — |
| Sep 11SEC | Terrence A. DuffyCEO, Chair | Sell | 62840,630 held (−2%) | $275.03 | $173K | +13.1% | — |
| Jun 29SEC | William R. ShepardDirectorRoutine (Jun buyer)Before earningsPast buys 9/19 beat S&P | Buy | 325260,442 held (+0%) | $230.57 | $75K | +34.9% | 45 |
| Jun 29SEC | William R. ShepardDirectorRoutine (Jun buyer)Before earningsPast buys 9/19 beat S&P | Buy | 143,621 held (+0%) | $230.57 | $3K | +34.9% | 45 |
| May 19SEC | Hilda Harris PiellSr Md & Chief Hr Officer | Sell | 5,75327,702 held (−17%) | $304.63 | $1.8M | +2.1% | — |
| May 18SEC | Terrence A. DuffyCEO, Chair | Sell | 25,99664,634 held (−29%) | $298.14 | $7.8M | +4.4% | — |
| May 18SEC | Terrence A. DuffyCEO, Chair | Sell | 9,00455,630 held (−14%) | $299.58 | $2.7M | +3.9% | — |
| Mar 30SEC | William R. ShepardDirectorRoutine (Mar buyer)Past buys 9/19 beat S&P | Buy | 1,408260,118 held (+1%) | $297.38 | $419K | +4.6% | 45 |
| Mar 30SEC | William R. ShepardDirectorRoutine (Mar buyer)Past buys 9/19 beat S&P | Buy | 622,539 held (+3%) | $297.38 | $18K | +4.6% | 45 |
| Mar 19SEC | Jonathan L. MarcusGeneral Counsel | Sell Plan | 3,2917,192 held (−31%) | $313.37 | $1.0M | -0.7% | — |
| Mar 12SEC | Ken VromanChief Transformation Officer | Sell | 5,16014,910 held (−26%) | $309.00 | $1.6M | +0.7% | — |
| Mar 9SEC | Elizabeth A. CookDirector | Sell | 1,00017,771 held (−5%) | $320.00 | $320K | -2.8% | — |
| Feb 23SEC | Bryan T. DurkinDirector | Sell | 4,20043,007 held (−9%) | $309.65 | $1.3M | +0.5% | — |
| Feb 20SEC | Martin J. GepsmanDirector | Sell | 30024,999 held (−1%) | $305.90 | $92K | +1.7% | — |
| Feb 9SEC | Dennis SuskindDirector | Sell | 7482,699 held (−22%) | $300.00 | $224K | +3.7% | — |
| Jan 2SEC | William R. ShepardDirectorRoutine (Jan buyer)Before earningsPast buys 9/19 beat S&P | Buy | 251258,710 held (+0%) | $278.37 | $70K | +11.8% | 45 |
| Jan 2SEC | William R. ShepardDirectorRoutine (Jan buyer)Before earningsPast buys 9/19 beat S&P | Buy | 112,477 held (+0%) | $278.37 | $3K | +11.8% | 45 |
| Dec 15SEC | Terrence A. DuffyCEO, Chair | Sell | 13,08977,715 held (−14%) | $269.10 | $3.5M | +15.6% | — |
| Dec 15SEC | Terrence A. DuffyCEO, Chair | Sell | 11,91165,804 held (−15%) | $270.05 | $3.2M | +15.2% | — |
| Nov 21SEC | Derek SammannSr Md Gl Hd Commodities Mkts | Sell | 5,88611,028 held (−35%) | $275.65 | $1.6M | +12.9% | — |
| Nov 21SEC | Derek SammannSr Md Gl Hd Commodities Mkts | Sell | 1,3147,022 held (−16%) | $275.74 | $362K | +12.8% | — |
| Nov 4SEC | Harold Eugene Ford Jr.Director | Sell | 1,0001,091 held (−48%) | $263.53 | $264K | +18.1% | — |
Similar past setups: not applicable. There aren't enough comparable past cases for CME's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with CME in the Research Lab
Pre-set to CME's latest insider buy of $10K or more (Sep 28, 2026: William R. Shepard, $79K). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
CME Group insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $661K and 14 sold $43.8M of CME stock on the open market; P/E 26.1 vs. a sector median of 11.9.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
CME insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $14.0M | 8 |
| Q3 2026 | $79K | 1 | $4.3M | 3 |
| Q2 2026 | $78K | 2 | $12.2M | 3 |
| Q1 2026 | $437K | 2 | $4.6M | 6 |
| Q4 2025 | $73K | 2 | $9.0M | 5 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 CME Group insider reported open-market purchases totaling $661K, while 14 insiders reported sales totaling $43.8M. Among insiders with enough purchase history to measure, William R. Shepard (Director) has the highest Insider Score at 45. 1 of 25 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
CME earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 21, 2026 | +9.4% | Bought $79K | +3.6%S&P -0.7% | pending |
| Jul 22, 2026 | +1.1% | Bought $75K | +7.1%S&P -1.3% | +8.1% |
| Apr 22, 2026 | -7.8% | Bought $437K | +0.4%S&P +0.6% | +2.0% |
| Feb 4, 2026 | +4.9% | None | +1.5%S&P -1.7% | +6.6% |
| Oct 22, 2025 | +2.5% | None | +0.1%S&P +0.1% | +1.6% |
| Jul 23, 2025 | -2.8% | None | +0.9%S&P +0.9% | -2.8% |
| Apr 23, 2025 | +5.2% | None | -0.9%S&P +3.7% | +7.9% |
| Feb 12, 2025 | +2.0% | None | +3.5%S&P +0.7% | +3.9% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
CME short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded CME
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +7.0% |
CME stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Earnings release
- 8-K Item 5.03
- 8-K Executive or board change
- 8-K Investor disclosure
What happened after CME insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Sep 28, 2026 | William R. ShepardDirector | $79K | +2.6%+1.4% vs S&P | +11.7%+10.8% vs S&P | pending |
| Jun 29, 2026 | William R. ShepardDirector | $78K | +7.4%+6.0% vs S&P | +21.4%+23.0% vs S&P | +21.0%+17.4% vs S&P |
| Mar 30, 2026 | William R. ShepardDirector | $437K | +3.7%-0.6% vs S&P | -3.5%-16.1% vs S&P | -26.2%-43.7% vs S&P |
| Jan 2, 2026 | William R. ShepardDirector | $73K | -2.7%-4.3% vs S&P | +7.8%+6.0% vs S&P | +15.8%+19.6% vs S&P |
Insiders at CME Group
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Terrence A. DuffyCEO, Chair | — | $29.7M | Nov 19, 2026 | 1 of 1 | — |
| Julie WinklerSr Md Chief Commercial Officer | — | $3.1M | Nov 2, 2026 | — | — |
| William R. ShepardDirector | $667K | — | Sep 28, 2026 | 9 of 19 | 45 |
| Derek SammannSr Md Gl Hd Commodities Mkts | — | $2.0M | Sep 17, 2026 | — | — |
| Hilda Harris PiellSr Md & Chief Hr Officer | — | $1.8M | May 19, 2026 | — | — |
| Ken VromanChief Transformation Officer | — | $1.6M | Sep 17, 2026 | — | — |
| Sunil CutinhoChief Information Officer | — | $1.5M | Oct 27, 2026 | — | — |
| Bryan T. DurkinDirector | — | $1.3M | Jun 29, 2026 | — | — |
| Jonathan L. MarcusGeneral Counsel | — | $1.0M | Mar 19, 2026 | — | — |
| Howard J. SiegelDirector | — | $606K | Nov 3, 2026 | — | — |
| Elizabeth A. CookDirector | — | $460K | Sep 14, 2026 | — | — |
| Harold Eugene Ford Jr.Director | — | $264K | Jun 29, 2026 | — | — |
| Dennis SuskindDirector | — | $224K | Jun 29, 2026 | — | — |
| Martin J. GepsmanDirector | — | $213K | Oct 22, 2026 | — | — |
| John Clifford MarcheseGeneral Counsel | — | $204K | Nov 19, 2026 | — | — |
| Daniel G. KayeDirector | — | $162K | Nov 10, 2026 | — | — |
| Lynne FitzpatrickCFO, President | — | — | Sep 17, 2026 | — | — |
| Suzanne SpragueCOO | — | — | Sep 17, 2026 | — | — |
| Michael G. DennisGlobal Head Of Fixed Income | — | — | Sep 17, 2026 | — | — |
| Timothy Francis McCourtSr Md Global Head Equity & Fx | — | — | Sep 17, 2026 | — | — |
| Jack J. TobinMd Chief Accounting Officer | — | — | Sep 17, 2026 | — | — |
| Deborah J. LucasDirector | — | — | Jun 29, 2026 | — | — |
| Charles P. CareyDirector | — | — | Jun 29, 2026 | — | — |
| Timothy S. BitsbergerDirector | — | — | Jun 29, 2026 | — | — |
| William W. HobertDirector | — | — | Jun 29, 2026 | — | — |
| Robert J. Tierney Jr.Director | — | — | Jun 29, 2026 | 1 of 1 | — |
| Phyllis M. LockettDirector | — | — | Jun 29, 2026 | — | — |
| Patrick W. MaloneyDirector | — | — | Jun 29, 2026 | — | — |
| Patrick J. MulchroneDirector | — | — | Jun 29, 2026 | — | — |
| Rahael SeifuDirector | — | — | Jun 29, 2026 | — | — |
| Kathryn BeneshDirector | — | — | Jun 29, 2026 | — | — |
Insider activity at other Financials companies
Same sector, ranked by insider buying in the last 90 days.
CME stock: common questions
Are CME Group insiders buying CME stock?
In the past 12 months, 1 insider reported open-market purchases of CME worth $661K. The latest was Director William R Shepard bought $79K of CME at $268.76.
Are CME Group insiders selling CME stock?
14 insiders reported sales worth $43.8M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CME's P/E ratio?
CME trades at about 26.1 times trailing earnings, compared with a median of 11.9 for the Financials sector.
What is CME's 52-week range?
Over the past year CME has traded between $217.56 and $319.37. It last closed at $311.15 on Nov 20, 2026.